Products for Research Use Only
RegisterLogin

CL2A

CAT: 0804-HY-128945-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-128945-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
CL2A is a claevable complicated PEG8- and triazole-containing PABC-peptide-mc linker. CL2A is cleavable through pH sensitivity, giving rise to bystander effect, and binds the antibody at a cysteine residue via a disulfide bond. Labetuzumab govitecan used this linker[1].
CAS Number
2616704-22-2
UNSPSC
12352203
Hazard Statement
H302, H315, H319, H335
Target
ADC Linker
Type
ADC Related
Related Pathways
Antibody-drug Conjugate/ADC Related
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/cl2a.html
Purity
98.20
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(NC1=CC=C(CO)C=C1)[C@H](CCCCN)NC(COCC(NCCOCCOCCOCCOCCOCCOCCOCCOCCN2N=NC(CNC(C3CCC(CN4C(C=CC4=O)=O)CC3)=O)=C2)=O)=O
Molecular Formula
C50H79N9O16
Molecular Weight
1062.21
Precautions
H302, H315, H319, H335
References & Citations
[1]Samantha Congreve, et al. Antibody drug conjugates (ADC) . Teknisk- naturvetenskaplig fakultet
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, protect from light)
Scientific Category
ADC Related
Clinical Information
Phase 2
Isoform
Cleavable Linker

Related Products

CatalogName
HY-139909CL2E-SN38
HY-139909A-01CL2E-SN38 (TFA)
HY-128947CL2 Linker
HY-145513CL2-MMT-SN38
HY-126350-01CL2-SN-38
HY-W013066-01Pd (Xantphos) Cl2
HY-179528DIM-3,5-Cl2
HY-157051[Ru (DIP) 2TAP]Cl2
HY-W018845-01[Ir (Cp-) Cl2]2
HY-W019734-01[Rh (Cp-) Cl2]2

Alternative Products

CatalogName
BA2432-10CL2A
GTR18406647-01CL2A Antibody
T205789-01CL2A-Chimmitecan
T205100-01CL2A-FL118
A18396-5CL2A 5mg
A18396-1CL2A 1mg
A18396-10CL2A 10mg
BA2624-50CL2A-SN-38
GTR19259530-01CL2A-SN38 (Govitecan)

Popular Products